SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001017491-18-000075
Filing Date
2018-08-09
Accepted
2018-08-09 16:04:42
Documents
61
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q apri6301810q.htm 10-Q 1006555
2 EXHIBIT 3.12 apri63018ex312.htm EX-3.12 15064
3 EXHIBIT 31.1 apri63018ex311.htm EX-31.1 11895
4 EXHIBIT 32.1 apri63018ex321.htm EX-32.1 5891
  Complete submission text file 0001017491-18-000075.txt   5229142

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT apri-20180630.xml EX-101.INS 734545
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT apri-20180630.xsd EX-101.SCH 55607
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT apri-20180630_cal.xml EX-101.CAL 60024
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT apri-20180630_def.xml EX-101.DEF 300082
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT apri-20180630_lab.xml EX-101.LAB 638530
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT apri-20180630_pre.xml EX-101.PRE 428018
Mailing Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130
Business Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130 (858) 222-8041
APRICUS BIOSCIENCES, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22245 | Film No.: 181004997
SIC: 2834 Pharmaceutical Preparations